5407012024-10-012024-12-315407012024-12-315407012024-10-012024-12-31CompositionOfBoardOfDirectors15407012024-12-31CompositionOfBoardOfDirectors15407012024-10-012024-12-31CompositionOfBoardOfDirectors25407012024-12-31CompositionOfBoardOfDirectors25407012024-10-012024-12-31CompositionOfBoardOfDirectors35407012024-12-31CompositionOfBoardOfDirectors35407012024-10-012024-12-31CompositionOfBoardOfDirectors45407012024-12-31CompositionOfBoardOfDirectors45407012024-10-012024-12-31CompositionOfBoardOfDirectors55407012024-12-31CompositionOfBoardOfDirectors55407012024-10-012024-12-31CompositionOfBoardOfDirectors65407012024-12-31CompositionOfBoardOfDirectors65407012024-10-012024-12-31CompositionOfBoardOfDirectors75407012024-12-31CompositionOfBoardOfDirectors75407012024-10-012024-12-31CompositionOfCommittees145407012024-12-31CompositionOfCommittees145407012024-10-012024-12-31CompositionOfCommittees155407012024-12-31CompositionOfCommittees155407012024-10-012024-12-31CompositionOfCommittees165407012024-12-31CompositionOfCommittees165407012024-10-012024-12-31CompositionOfCommittees175407012024-12-31CompositionOfCommittees175407012024-10-012024-12-31CompositionOfCommittees415407012024-12-31CompositionOfCommittees415407012024-10-012024-12-31CompositionOfCommittees425407012024-12-31CompositionOfCommittees425407012024-10-012024-12-31CompositionOfCommittees435407012024-12-31CompositionOfCommittees435407012024-10-012024-12-31CompositionOfCommittees445407012024-12-31CompositionOfCommittees445407012024-10-012024-12-31CompositionOfCommittees685407012024-12-31CompositionOfCommittees685407012024-10-012024-12-31CompositionOfCommittees695407012024-12-31CompositionOfCommittees695407012024-10-012024-12-31CompositionOfCommittees705407012024-12-31CompositionOfCommittees705407012024-10-012024-12-31CompositionOfCommittees955407012024-12-31CompositionOfCommittees955407012024-10-012024-12-31CompositionOfCommittees965407012024-12-31CompositionOfCommittees965407012024-10-012024-12-31CompositionOfCommittees975407012024-12-31CompositionOfCommittees975407012024-10-012024-12-31CompositionOfCommittees985407012024-12-31CompositionOfCommittees985407012024-12-31MeetingOfBoardOfDirectors15407012024-10-012024-12-31MeetingOfBoardOfDirectors15407012024-12-31MeetingOfBoardOfDirectors25407012024-10-012024-12-31MeetingOfBoardOfDirectors25407012024-12-31MeetingOfBoardOfDirectors35407012024-10-012024-12-31MeetingOfBoardOfDirectors35407012024-10-012024-12-31MeetingOfCommittees15407012024-12-31MeetingOfCommittees15407012024-10-012024-12-31MeetingOfCommittees25407012024-12-31MeetingOfCommittees25407012024-10-012024-12-31MeetingOfCommittees35407012024-12-31MeetingOfCommittees35407012024-10-012024-12-31MeetingOfCommittees45407012024-12-31MeetingOfCommittees45407012024-10-012024-12-31MeetingOfCommittees55407012024-12-31MeetingOfCommittees55407012024-10-012024-12-31MeetingOfCommittees65407012024-12-31MeetingOfCommittees65407012024-09-30xbrli:pure540701DCALNOTLISTEDINE385W01011DISHMAN CARBOGEN AMCIS LIMITED2024-04-012025-03-31Quarterly2024-12-31EquitytruetruefalseNot Applicable for this quarterfalseNot Applicable for this quarterfalseNot Applicable for this quartertrueTop 1000 listed entitiestrued00437Original Note: (I) As required by Regulation 26(1) of SEBI (LODR) Regulations, 2015, the disclosure includes Membership and Chairmanship of Audit Committees and Stakeholders Relationship Committees in all public limited Companies (listed or unlisted) (II) While counting Membership of Ms. Maitri K. Mehta, we have considered her membership held in Audit Committee of three Private Limited Copanies which are deemed Public Companies as per the provision of the Companis Act, 2013. (III) Note on Initial Date of Appointment of Directors in the Company: 1. Initially, Mr. Janmejay R. Vyas has been appointed as Non-Executive Promoter Director in the Company since its incorporation i.e. 17th July, 2007. Thereafter, he has been appointed as a Chairman & Managing Director of the Company pursuant to the Scheme of Arrangement and Amalgamation amongst the Company; Dishman Pharmaceuticals and Chemicals Ltd. (DPCL); Dishman Care Limited and their respective Shareholders& Creditors ("Scheme") duly sanctioned by Honble High Court of Gujarat vide order dated 16th December, 2016. Accordingly, DPCL has been merged into the Company. As per the said Scheme, Directors of DPCL shall require to be appointed on the board of the Company. Hence, Mr. Janmejay R. Vyas, who is also a Chairman & Managing Director on the Board of DPCL has been appointed with his existing terms and conditions as approved by the Board of Directors and Shareholders of Amalgamating Company viz. DPCL i.e. w.e.f. 1st March, 2015, upon coming into effect of the said Scheme on 17th March, 2017. Subsequently, Mr. Janmejay R. Vyas, Chairman& Managing Director of the Company has been stepped down from the role of Managing Director w.e.f. 18th February, 2019. 2. Mrs. Deohooti J. Vyas has been appointed as a Whole-time Director of the Company pursuant to the Scheme of Arrangement and Amalgamation amongst the Company; Dishman Pharmaceuticals and Chemicals Ltd. (DPCL); Dishman Care Limited and their respective Shareholders & Creditors ("Scheme") duly sanctioned by Honble High Court of Gujarat vide order dated 16th December, 2016. Accordingly, DPCL has been merged into the Company. As per the said Scheme, Directors of DPCL shall require to be appointed on the board of the Company, hence, Mrs. Deohooti J. Vyas has been appointed with her existing terms and conditions as approved by the Board of Directors and Shareholders of Amalgamating Company viz. DPCL i.e. w.e.f. 3rd September, 2016, upon coming into effect of the said Scheme on 17th March, 2017. 3. Initially, Mr. Arpit J. Vyas has been appointed as Non-Executive Promoter Director in the Company w.e.f. 7th April, 2012. Thereafter, he has been appointed as a Managing Director of the Company pursuant to the Scheme of Arrangement and Amalgamation amongst the Company; Dishman Pharmaceuticals and Chemicals Ltd. (DPCL); Dishman Care Limited and their respective Shareholders & Creditors ("Scheme") duly sanctioned by Honble High Court of Gujarat vide order dated 16th December, 2016. Accordingly, DPCL has been merged into the Company. As per the said Scheme, Directors of DPCL shall require to be appointed on the board of the Company. Hence, Mr. Arpit J. Vyas, who is also a Managing Director & CFO of DPCL has been appointed with his existing terms and conditions as approved by the Board of Directors and Shareholders of Amalgamating Company viz. DPCL i.e. w.e.f. 1st June, 2014, upon coming into effect of the said Scheme on 17th March, 2017. Subsequently, Mr. Arpit J. Vyas, who was Managing Director and CFO of Dishman Carbogen Amcis Limited, has been elevated to the role of Global Managing Director w.e.f. 26th November, 2018. 4. Mr. Rajendra S. Shah has been appointed as an Independent Director of the Company pursuant to the Scheme of Arrangement and Amalgamation amongst the Company; Dishman Pharmaceuticals and Chemicals Ltd. (DPCL); Dishman Care Limited and their respective Shareholders & Creditors ("Scheme") duly sanctioned by Honble High Court of Gujarat vide order dated 16th December, 2016. Accordingly, DPCL has been merged into the Company. As per the said Scheme, Directors of DPCL shall require to be appointed on the board of the Company, hence, Mr. Rajendra S. Shah has been appointed as an Independent Director with his existing terms and conditions as approved by the Board of Directors and Shareholders of Amalgamating Company viz. DPCL i.e. w.e.f. 2nd April, 2015, upon coming into effect of the said Scheme on 17th March, 2017. 5. Mr. Subir Kumar Das has been appointed as an Independent Director of the Company pursuant to the Scheme of Arrangement and Amalgamation amongst the Company; Dishman Pharmaceuticals and Chemicals Ltd. (DPCL); Dishman Care Limited and their respective Shareholders& Creditors ("Scheme") duly sanctioned by Honble High Court of Gujarat vide order dated 16th December, 2016. Accordingly, DPCL has been merged into the Company. As per the said Scheme, Directors of DPCL shall require to be appointed on the Board of the Company, hence, Mr. Subir Kumar Das has been appointed as an Independent Director with his existing terms and conditions as approved by the Board of Directors and Shareholders of Amalgamating Company viz. DPCL i.e. w.e.f. 15th December, 2014, upon coming into effect of the said Scheme on 17th March, 2017. Further to the above, Mr. Subir Kumar Das (DIN: 02237356) has completed his second and final term as an Independent Director and consequently ceased as Director of the Company w.e.f. 15th December, 2024. Accordingly, as on 31.12.2024 we have mentioned their details as zero under the heads No. of Directorship in listed entities including this listed entity; No. of Independent Directorship in listed entities including this listed entity; No. of memberships in Audit/ Stakeholder Committees including this listed entity and No of post of Chairperson in Audit/ Stakeholder Committees held in listed entities including this listed entity.truetrueMrVyas Janmejay R00004730Non-Executive - Non Independent DirectorChairperson related to Promoter1951-04-29falseActiveNA2015-03-011010MrsDeohooti Janmejay Vyas00004876Executive DirectorNot Applicable1951-10-15falseActiveNA2016-09-032021-09-031000MrArpit Janmejay Vyas01540057Executive DirectorNot ApplicableMD1986-07-28falseActiveNA2014-06-012024-06-011000MrShah Rajendra Shantilal00061922Non-Executive - Independent DirectorNot Applicable1948-02-01falseActiveYes2019-09-242015-04-022020-04-02116.35352MrSubir Kumar Das02237356Non-Executive - Independent DirectorNot Applicable1953-11-18falseActiveNA2014-12-152019-12-152024-12-151200000Tenure CompletionMsMaitri K Mehta07549243Non-Executive - Independent DirectorNot Applicable1981-12-17falseActiveNA2019-04-012024-04-01693390MrKulin Nalinkant Shah01863481Non-Executive - Independent DirectorNot Applicable1967-08-30falseActiveNA2024-11-131.191110truetruetruetrueAudit Committee00061922Shah Rajendra ShantilalNon-Executive - Independent DirectorChairperson2024-04-01Audit Committee02237356Subir Kumar DasNon-Executive - Independent DirectorMember2017-03-172024-12-15 Mr. Subir Kumar Das has been appointed as an Independent Director of the Company pursuant to the Scheme of Arrangement and Amalgamation amongst the Company; Dishman Pharmaceuticals and Chemicals Ltd. (DPCL); Dishman Care Limited and their respective Shareholders & Creditors ("Scheme") duly sanctioned by Honble High Court of Gujarat vide order dated 16th December, 2016. Accordingly, DPCL has been merged into the Company. As per the said Scheme, Directors of DPCL shall require to be appointed on the Board of the Company, hence, Mr. Subir Kumar Das has been appointed with his existing terms and conditions as approved by the Board of Directors and Shareholders of Amalgamating Company viz. DPCL i.e. w.e.f. 15th December, 2014, upon coming into effect of the said Scheme on 17th March, 2017. After Merger, all committees of erstwhile DPCL became applicable to the Company and existing committee members of Audit Committee became the member of the Audit Committee of the Company w.e.f. 17th March, 2017. Further to the above, Mr. Subir Kumar Das (DIN: 02237356) has completed his second and final term as an Independent Director and consequently ceased as Director of the Company w.e.f. 15th December, 2024. Audit Committee07549243Maitri K MehtaNon-Executive - Independent DirectorMember2024-04-01Audit Committee01863481Kulin Nalinkant ShahNon-Executive - Independent DirectorMember2024-12-15Nomination and remuneration committee00061922Shah Rajendra ShantilalNon-Executive - Independent DirectorChairperson2024-04-01Nomination and remuneration committee02237356Subir Kumar DasNon-Executive - Independent DirectorMember2017-03-172024-12-15 Mr. Subir Kumar Das has been appointed as an Independent Director of the Company pursuant to the Scheme of Arrangement and Amalgamation amongst the Company; Dishman Pharmaceuticals and Chemicals Ltd. (DPCL); Dishman Care Limited and their respective Shareholders & Creditors ("Scheme") duly sanctioned by Honble High Court of Gujarat vide order dated 16th December, 2016. Accordingly, DPCL has been merged into the Company. As per the said Scheme, Directors of DPCL shall require to be appointed on the Board of the Company, hence, Mr. Subir Kumar Das has been appointed with his existing terms and conditions as approved by the Board of Directors and Shareholders of Amalgamating Company viz. DPCL i.e. w.e.f. 15th December, 2014, upon coming into effect of the said Scheme on 17th March, 2017. After Merger, all committees of erstwhile DPCL became applicable to the Company and existing committee members of Nomination and Remuneration Committee became the member of the Nomination and Remuneration Committee of the Company w.e.f. 17th March, 2017. Further to the above, Mr. Subir Kumar Das (DIN: 02237356) has completed his second and final term as an Independent Director and consequently ceased as Director of the Company w.e.f. 15th December, 2024. Nomination and remuneration committee07549243Maitri K MehtaNon-Executive - Independent DirectorMember2024-04-01Nomination and remuneration committee01863481Kulin Nalinkant ShahNon-Executive - Independent DirectorMember2024-12-15Stakeholders Relationship Committee00061922Shah Rajendra ShantilalNon-Executive - Independent DirectorChairperson2024-04-01Stakeholders Relationship Committee00004730Vyas Janmejay RNon-Executive - Non Independent DirectorMember2017-03-17 Initially, Mr. Janmejay R. Vyas has been appointed as Non-Executive Promoter Director in the Company since its incorporation i.e. 17th July, 2007. Thereafter, he has been appointed as a Chairman & Managing Director of the Company pursuant to the Scheme of Arrangement and Amalgamation amongst the Company; Dishman Pharmaceuticals and Chemicals Ltd. (DPCL); Dishman Care Limited and their respective Shareholders & Creditors ("Scheme") duly sanctioned by Honble High Court of Gujarat vide order dated 16th December, 2016. Accordingly, DPCL has been merged into the Company. As per the said Scheme, Directors of DPCL shall require to be appointed on the board of the Company. Hence, Mr. Janmejay R. Vyas, who is also a Chairman & Managing Director on the Board of DPCL has been appointed with his existing terms and conditions as approved by the Board of Directors and Shareholders of Amalgamating Company viz. DPCL i.e. w.e.f. 1st March, 2015, upon coming into effect of the said Scheme on 17th March, 2017. Subsequently, Mr. Janmejay R. Vyas, Chairman & Managing Director of the Company has been stepped down from the role of Managing Director w.e.f. 18th February, 2019. After Merger, all committees of erstwhile DPCL became applicable to the Company and existing committee members of Stakeholders Relationship Committee became the member of the Stakeholders Relationship Committee of the Company w.e.f. 17th March, 2017. Stakeholders Relationship Committee07549243Maitri K MehtaNon-Executive - Independent DirectorMember2024-04-01Risk Management Committee01540057Arpit Janmejay VyasExecutive DirectorChairperson2019-01-23Risk Management Committee00004730Vyas Janmejay RNon-Executive - Non Independent DirectorMember2019-01-23Risk Management Committee06481203Harshil Ramakant DalalGlobal CFOMember2019-01-23As per Regulation 21(2) of SEBI LODR, the Company has constituted Risk Management Committee comprising of majority of Board Members including one Independent Director.Risk Management Committee07549243Maitri K MehtaNon-Executive - Independent DirectorMember2024-04-012024-08-13true6432024-09-23true6532024-11-1350true663Audit Committee2024-08-13true3330Audit Committee2024-11-1391true3330Stakeholders Relationship Committee2024-08-13true3220Stakeholders Relationship Committee2024-11-1391true3320Nomination and remuneration committee2024-11-13true3330Risk Management Committee2024-11-13true3311truetruetruetrueYestruetruetrueSHRIMA DAVECompany Secretary and Compliance OfficerfalseSHRIMA DAVECompany Secretary and Compliance OfficerAHMEDABAD2025-01-2800000